Clinical Trial Update: The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial on levothyroxine for goiter with atypia of undetermined significance has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Goiter

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: Sheng-Chiang Su | Conditions: Goiter | Phase 4 | Status: WITHDRAWN